Leadership

Officers

Dr. John Keller (President)
President & CEO
Shionogi Inc.

Ms. Brianne Weingarten (Secretary)
Head of Alliance Management
Licensing & Business Development
Purdue Pharma L.P.

Mr. Shoji Yasuda (Treasurer)
President
Taisho Pharmaceutical R&D Inc.

Members of
The Board of Directors

Dr. Rana Al-Hallaq
Director, Business Development
Pfizer Inc.

Dr. Alex Chang
Executive Director Business Development
Helsinn Therapeutics (U.S.) Inc.

Ms. Theresa Covert
AVP, Business Development/Developed Markets,
Global Human Health
Merck & Co., Inc.

Dr. Toby Freyman
Director, Business Development
Shire

Dr. Hiroshi Kawai
Vice President, Business Development
Mitsubishi Tanabe Pharma Holdings America, Inc.

Dr. John Keller
President & CEO
Shionogi Inc.

Mr. Mitsuo Kosaka
Vice President, U.S. Payer Markets & Corporate Strategy
Eisai Inc.

Mr. Sang Le
Senior Director of Alliance Management
Otsuka America Pharmaceuticals

Dr. Blaine McKee
Executive Vice President and  Chief Business Officer
ImmunoGen, Inc.

Mr. Kazumi Taguchi 
President
Kyorin USA Inc.

Dr. Jeffrey Warmke
Senior Vice President, External Scientific Affairs & Alliance Management, Global Business Development                                                       Daiichi Sankyo Inc.

Ms. Brianne Weingarten
Head of Alliance Management
Licensing and Business Development
Purdue Pharma L.P.

Mr. Tim Whitten
Chief Operating Officer
Taiho Oncology, Inc.

Mr. Shoji Yasuda
President
Taisho Pharmaceutical R&D Inc.